Related Experiment Video
Updated: Feb 20, 2026
06:11
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
Published on: May 2, 2025
626
Primary Hepatic Angiosarcoma: A Case Report with 10-Year Patient Medical Data
Masanori Ogawa1, Ryusuke Ae2, Teppei Sasahara3
1Health Service Center, Jichi Medical University, Tochigi, Japan.
Case Reports in Oncology
|October 27, 2017
Summary
This case study presents a rare hepatic angiosarcoma (HAS) in a patient with chronic fatty liver and cirrhosis, highlighting the need for further research into non-carcinogen-associated liver cancer. The patient
Area of Science:
- Hepatology
- Oncology
- Pathology
Background:
- Hepatic angiosarcoma (HAS) is a rare primary liver cancer.
- Chronic exposure to carcinogens like vinyl chloride is a known risk factor for HAS.
- The association between non-carcinogenic factors, such as chronic fatty liver disease, and HAS development is not well understood.
Observation:
- A 46-year-old man presented with sudden abdominal pain, diagnosed with ruptured HAS.
- The patient had a history of fatty liver for over 10 years and was diagnosed with liver cirrhosis.
- No history of exposure to known HAS-associated carcinogens was reported.
Findings:
- This is a rare case of HAS developing in a cirrhotic liver with a history of chronic fatty liver.
- The patient's condition rapidly progressed, leading to death 13 days post-surgery.
- The case underscores the potential role of chronic fatty liver in HAS tumorigenesis, independent of traditional carcinogen exposure.
Implications:
- Further research is needed to elucidate the pathophysiology of HAS in the context of non-carcinogenic risk factors like fatty liver disease.
- This case highlights the importance of comprehensive health data collection for rare cancers.
- Early detection and understanding of HAS development in patients with underlying liver conditions are crucial.
